
95% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
REVIEW article
Front. Chem.
Sec. Chemical Physics and Physical Chemistry
Volume 13 - 2025 | doi: 10.3389/fchem.2025.1553461
This article is part of the Research Topic Advanced Functional Materials, Structures and Devices for Advancing Human Healthcare Applications View all 6 articles
The final, formatted version of the article will be published soon.
You have multiple emails registered with Frontiers:
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
In recent years, micro-nano robots have found extensive applications in the field of medicine. Among these, micro-nano robots demonstrate significant potential for the treatment of eye diseases. Micro-nano robots can penetrate eye tissue barriers to directly target the posterior segment of the eye for precise drug delivery, enabling non-invasive or minimally invasive treatment. This review explores the primary fabrication methods and propulsion mechanisms of various micro-nano robots, and their applications in treating various eye conditions, offering inspiration and guidance for advancing the use of micro-nanorobots in ophthalmic therapies.
Keywords: micro-nano robots, Eye Diseases, Drug delivery, On-target drug delivery, applications
Received: 30 Dec 2024; Accepted: 31 Mar 2025.
Copyright: © 2025 Wang, Sun, Zhang, Zhou, Zhang, Ni, Wang, Wu, Sun, Zhao and Qiao. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Hong Qiao, Department of Endocrinology, The Second Affiliated Hospital of Harbin Medical University, Harbin, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Research integrity at Frontiers
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.